Ulland Investment Advisors LLC Has $7.86 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Ulland Investment Advisors LLC trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 31.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,939 shares of the biotechnology company's stock after selling 6,931 shares during the quarter. Axon Enterprise accounts for 6.6% of Ulland Investment Advisors LLC's portfolio, making the stock its 2nd biggest holding. Ulland Investment Advisors LLC's holdings in Axon Enterprise were worth $7,857,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in AXON. Fourth Dimension Wealth LLC bought a new stake in Axon Enterprise in the fourth quarter worth $30,000. Elequin Capital LP bought a new position in shares of Axon Enterprise during the fourth quarter valued at $46,000. Stonebridge Financial Group LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at $53,000. CoreFirst Bank & Trust bought a new position in shares of Axon Enterprise during the fourth quarter valued at $59,000. Finally, Global Financial Private Client LLC lifted its holdings in shares of Axon Enterprise by 11,100.0% during the first quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company's stock valued at $59,000 after purchasing an additional 111 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 9,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $683.31, for a total value of $6,149,790.00. Following the transaction, the president now directly owns 308,714 shares of the company's stock, valued at approximately $210,947,363.34. The trade was a 2.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,969 shares of company stock valued at $29,909,594 over the last 90 days. Company insiders own 4.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on AXON shares. Needham & Company LLC upped their price target on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Bank of America upped their price target on Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. Barclays upped their price target on Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Finally, Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Stock Performance

AXON traded up $5.43 during midday trading on Friday, reaching $780.63. The company had a trading volume of 358,906 shares, compared to its average volume of 719,761. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a 50-day moving average of $669.47 and a two-hundred day moving average of $621.44. The company has a market cap of $60.77 billion, a P/E ratio of 201.71, a P/E/G ratio of 5.17 and a beta of 1.29. Axon Enterprise, Inc. has a 1 year low of $279.02 and a 1 year high of $806.64.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. The business had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business's quarterly revenue was up 31.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.15 earnings per share. As a group, equities research analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.